WallStreetZenWallStreetZen

NASDAQ: MDLN
Medline Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MDLN

Based on 24 analysts offering 12 month price targets for Medline Inc

Min Forecast
$40.00+10.53%
Avg Forecast
$50.13+38.51%
Max Forecast
$62.00+71.32%

Should I buy or sell MDLN stock?

Based on 24 analysts offering ratings for Medline Inc.

Strong Buy
Strong Buy
11 analysts 45.83%
Buy
9 analysts 37.5%
Hold
4 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MDLN's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates MDLN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their MDLN stock forecasts and price targets.

MDLN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-14
lockedlocked$00.00+00.00%2026-05-13
lockedlocked$00.00+00.00%2026-05-07
lockedlocked$00.00+00.00%2026-05-07
lockedlocked$00.00+00.00%2026-05-07
JP Morgan
Top 22%
79
Strong BuyMaintains$53.00+46.45%2026-03-10
Morgan Stanley
Top 44%
57
Strong BuyMaintains$52.00+43.69%2026-03-02
Wells Fargo
Top 12%
89
HoldMaintains$47.00+29.87%2026-02-27
UBS
Top 19%
82
Strong BuyMaintains$57.00+57.50%2026-02-26
BMO Capital
Top 31%
70
BuyMaintains$54.00+49.21%2026-02-26

1 of 3

Forecast return on equity

Is MDLN forecast to generate an efficient return?

Company
25.72%
Industry
24.61%
Market
170.34%
MDLN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MDLN forecast to generate an efficient return on assets?

Company
7.43%
Industry
18.33%
MDLN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MDLN earnings per share forecast

What is MDLN's earnings per share in the next 3 years based on estimates from 30 analysts?

Avg 1 year Forecast
$1.50
Avg 2 year Forecast
$1.69
Avg 3 year Forecast
$1.92

MDLN revenue forecast

What is MDLN's revenue in the next 3 years based on estimates from 30 analysts?

Avg 1 year Forecast
$31.5B
Avg 2 year Forecast
$34.0B
Avg 3 year Forecast
$36.6B

MDLN vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
MDLN$36.19$50.13+38.51%Strong Buy
BDX$143.47$184.69+28.73%Buy
ALC$63.64$84.13+32.19%Buy
RMD$201.88$284.71+41.03%Buy
WST$302.89$305.00+0.70%Hold
View Top Medical Stocks

Medline Stock Forecast FAQ

Is Medline Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 24 Wall Street analysts covering (NASDAQ: MDLN) stock is to Strong Buy MDLN stock.

Out of 24 analysts, 11 (45.83%) are recommending MDLN as a Strong Buy, 9 (37.5%) are recommending MDLN as a Buy, 4 (16.67%) are recommending MDLN as a Hold, 0 (0%) are recommending MDLN as a Sell, and 0 (0%) are recommending MDLN as a Strong Sell.

If you're new to stock investing, here's how to buy Medline stock.

What is MDLN's earnings growth forecast for 2026-2028?

(NASDAQ: MDLN) Medline's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 26.41%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.06%.

Medline's earnings in 2026 is N/A.On average, 30 Wall Street analysts forecast MDLN's earnings for 2026 to be $1,967,642,132, with the lowest MDLN earnings forecast at $1,789,506,017, and the highest MDLN earnings forecast at $2,165,614,938. On average, 30 Wall Street analysts forecast MDLN's earnings for 2027 to be $2,221,315,317, with the lowest MDLN earnings forecast at $2,008,366,465, and the highest MDLN earnings forecast at $2,524,251,807.

In 2028, MDLN is forecast to generate $2,518,997,054 in earnings, with the lowest earnings forecast at $2,252,975,201 and the highest earnings forecast at $2,731,157,693.

What is MDLN's revenue growth forecast for 2026-2028?

(NASDAQ: MDLN) Medline's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.69%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.02%.

Medline's revenue in 2026 is N/A.On average, 30 Wall Street analysts forecast MDLN's revenue for 2026 to be $41,414,019,370,100, with the lowest MDLN revenue forecast at $39,520,994,725,776, and the highest MDLN revenue forecast at $42,926,074,446,864. On average, 30 Wall Street analysts forecast MDLN's revenue for 2027 to be $44,606,281,608,620, with the lowest MDLN revenue forecast at $42,405,853,933,920, and the highest MDLN revenue forecast at $46,748,907,004,104.

In 2028, MDLN is forecast to generate $48,087,555,243,220 in revenue, with the lowest revenue forecast at $45,699,270,161,068 and the highest revenue forecast at $50,959,277,569,724.

What is MDLN's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: MDLN) forecast ROA is 7.43%, which is lower than the forecast US Medical Instruments & Supplies industry average of 18.33%.

What is MDLN's Price Target?

According to 24 Wall Street analysts that have issued a 1 year MDLN price target, the average MDLN price target is $50.13, with the highest MDLN stock price forecast at $62.00 and the lowest MDLN stock price forecast at $40.00.

On average, Wall Street analysts predict that Medline's share price could reach $50.13 by May 14, 2027. The average Medline stock price prediction forecasts a potential upside of 38.51% from the current MDLN share price of $36.19.

What is MDLN's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: MDLN) Medline's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that MDLN's EPS will be $1.50 for 2026, with the lowest EPS forecast at $1.36, and the highest EPS forecast at $1.65. On average, analysts forecast that MDLN's EPS will be $1.69 for 2027, with the lowest EPS forecast at $1.53, and the highest EPS forecast at $1.92. In 2028, MDLN's EPS is forecast to hit $1.92 (min: $1.72, max: $2.08).

What is MDLN's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: MDLN) forecast ROE is 25.72%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.